While extensive research has explored interconnectedness, volatility spillovers, and risk transmission across financial systems, the comparative dynamics between Islamic and conventional banks during crises, particularly in specific regions such as Saudi Arabia, are underexplored. This study investigates risk transmissions and contagion among banks operating in Islamic and conventional modes in the Kingdom of Saudi Arabia. Daily banking stock data spanning November 2018 to November 2023, encompassing two major crises—COVID-19 and the Russian-Ukraine war—were analyzed. Using the frequency TVP-VAR approach, the study reveals that average total connectedness for both banking groups exceeds 50%, with short-run risk transmission dominating over long-term effects. Graphical visualizations highlight time-varying connectedness, driven predominantly by short-run spillovers, with similar patterns observed in both Islamic and conventional banking networks. The main contribution of this paper is the insight that long-term investment strategies are crucial for mitigating potential risks in the Saudi banking system, given its limited diversification opportunities.

This review discusses the significant progress made in the development of CNT/GO-based biosensors for disease biomarker detection. It highlights the specific applications of CNT/GO-based biosensors in the detection of various disease biomarkers, including cancer, cardiovascular diseases, infectious diseases, and neurodegenerative disorders. The superior performance of these biosensors, such as their high sensitivity, low detection limits, and real-time monitoring capabilities, makes them highly promising for early disease diagnosis. Moreover, the challenges and future directions in the field of CNT/GO-based biosensors are discussed, focusing on the need for standardization, scalability, and commercialization of these biosensing platforms. In conclusion, CNT/GO-based biosensors have demonstrated immense potential in the field of disease biomarker detection, offering a promising approach towards early diagnosis. Continued research and development in this area hold great promise for advancing personalized medicine and improving patient outcomes.